% | $
Quotes you view appear here for quick access.

Roche Holding AG Message Board

  • mickmack50 mickmack50 Feb 24, 2014 5:52 PM Flag

    Roche Better Pick Up PSDV For Sustained Biologic Release.

    Eylea just approved today for DME. Shouldn't Roche pick them up on the cheap for their biosilicon platform to deliver biologics? They'll lose market share to Eylea in a big way going forward for all ophthalmic applications. Sustained release will help them a big way.

31.540.00(-0.02%)Sep 23 3:59 PMEDT